1. 2137 Comparison of two Phase II trials of mFOLFOX6 plus bevacizumab (KSCC0802) and SOX (S-1 and oxaliplatin) plus cetuximab (KSCC1002): First line chemotherapy in colorectal cancer patients with initially unresectable or not optimally resectable liver only metastases. (September 2015) Authors: Oki, E.; Emi, Y.; Miyamoto, Y.; Ogata, Y.; Tokunaga, S.; Shirabe, K.; Beppu, T.; Uchida, S.; Takatsuki, M.; Sakoda, M.; Eguchi, S.; Akagi, Y.; Kakeji, Y.; Baba, H.; Natsugoe, S.; Maehara, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗